DewCell
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
DewCell - overview
Established
2021
Location
Seongnam-si, Gyeonggido, South Korea
Primary Industry
Biotechnology
About
Founded in 2021 and based in Seongnam, South Korea, DewCell operates as a biotechnology company that is developing artificial platelets using human-derived stem cell-induced differentiation technology and biomimetic technology to solve the blood donation shortage problem. In March 2026, DewCell raised KRW 23. 5 billion in series C funding from new investors Hanwha Investment & Securities, WONIK Investment Partners, Hyundai Investment Partners, KDB Capital, Korea SMEs and Startups Agency. Other unspecified investors also participated in this round.
As of 2024, the company is led by its CEO, Lee Min-woo. The company’s pipeline includes the En-aPLT™ platform for manufacturing artificial platelets derived from stem cells and the i-aPLP™ platform for creating induced pluripotent stem cell-derived artificial platelet analogues. Dewcell is advancing i-ahPLys™, which is a technology for producing artificial human platelet lysate from induced pluripotent stem cells. The company will use the March 2026 funding to upgrade its production infrastructure.
Current Investors
Innopolis Partners, Korea Tech Incubator for Startup, Korea Development Bank
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Healthcare IT
Website
www.dewcellbio.com/
Company Stage
Series C
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.